AUTOTAXIN INHIBITORY COMPOUNDS

The present invention relates to compounds of formula I, wherein A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar and Q are each as defined herein. The compounds of the present invention are inhibitors of autotaxin (ATX) enzyme activity. The present invention also relates to processes for the preparation o...

Full description

Saved in:
Bibliographic Details
Main Authors SHAH, PRITOM, STOCKLEY, MARTIN LEE, HITCHIN, JAMES, JORDAN, ALLAN, MACDONALD, ELLEN CATHERINE, HAMILTON, NIALL
Format Patent
LanguageEnglish
French
Published 28.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds of formula I, wherein A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar and Q are each as defined herein. The compounds of the present invention are inhibitors of autotaxin (ATX) enzyme activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions (e.g. fibrosis) in which ATX activity is implicated. La présente invention concerne des composés de formule (I), dans laquelle A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar et Q sont chacun tels que définis dans la description. Les composés de la présente invention sont des inhibiteurs de l'activité enzymatique de l'autotaxine (ATX). La présente invention concerne également des procédés de préparation de ces composés, des compositions pharmaceutiques les comprenant, et leur utilisation dans le traitement de troubles prolifératifs, tels que le cancer, ainsi que d'autres maladies ou états pathologiques (par exemple, la fibrose) dans lesquels est impliquée l'activité d'ATX.
Bibliography:Application Number: CA20162974266